How the Glaucoma Research Foundation Has Impacted Patient Care For More Than Four Decades – Tom Brunner

How the Glaucoma Research Foundation Has Impacted Patient Care For More Than Four Decades – Tom Brunner

Tom Brunner, President and CEO of Glaucoma Research Foundation (GRF), shares the history of ophthalmic laser technology and how he ended up leading a global organization dedicated to funding promising Glaucoma research. Tom further provides a detailed overview of Glaucoma onset and progression, highlighting risk factors and the importance of early diagnosis. Some of the most significant clinical trials in Glaucoma in recent decades—funded by GRF—are also discussed.



Nine Years of Innovation Catalyst for a Cure Report

Glaucoma Research Foundation learn more and donate

About the guest:

Tom Brunner joined Glaucoma Research Foundation in 2003 after a successful 30-year career in the ophthalmic laser business. He helped introduce major advances in eye care including laser photocoagulation to prevent vision loss from diabetic retinopathy, laser treatment of secondary cataracts, and laser treatment for glaucoma.

Since joining Glaucoma Research Foundation, Tom has helped to more than double revenue and focus on innovative research to understand how glaucoma steals sight and find a cure. He received a “Lifetime Achievement” award from the American Society for Laser Medicine and Surgery for his contributions and 25 years of service on their Board of Directors.

Tom actively supports development of new products to help those with glaucoma and other eye diseases as an advisor or board member for startup companies in the eye care field. Tom graduated from Lehigh University with a degree in electrical engineering and received an MBA from the University of Delaware.

Leave a Reply

Your email address will not be published.

*